Elite in High Cholesterol

Bertrand Cariou

Nantes, FR 
Elite in High Cholesterol
Nantes, FR 
OverviewLocationsClinical Research

Overview

Bertrand Cariou practices in Nantes, France. Cariou is rated as an Elite expert by MediFind in the treatment of High Cholesterol. Their top areas of expertise are Type 2 Diabetes (T2D), Low Blood Sugar, High Cholesterol, Parathyroidectomy, and Sleeve Gastrectomy.

Their clinical research consists of co-authoring 303 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 55 articles and participated in 1 clinical trial in the study of High Cholesterol.

Locations

Nantes, France
Other Locations
Doue, France
Dijon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: November 18, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
Screening for NAFLD-related Advanced Fibrosis in High Risk popuLation: Optimization of the Diabetology Pathway Referral Using Combinations of Non-invAsive Biological and elastogRaphy paramEters
Screening for NAFLD-related Advanced Fibrosis in High Risk popuLation: Optimization of the Diabetology Pathway Referral Using Combinations of Non-invAsive Biological and elastogRaphy paramEters
Enrollment Status: Completed
Publish Date: February 11, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Liver and Metabolic Effects of Insulin Pump Therapy in a Population of Type 2 Diabetics with Non-alcoholic Hepatic Steatosis
Liver and Metabolic Effects of Insulin Pump Therapy in a Population of Type 2 Diabetics with Non-alcoholic Hepatic Steatosis
Enrollment Status: Completed
Publish Date: October 17, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life
Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life
Enrollment Status: Terminated
Publish Date: July 26, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Kinetic Study of Lipoprotein in Humans for a Better Understanding of Lipoprotein(a) Metabolism Under PCSK9 Variations (Hu-La-u-P Study)
A Kinetic Study of Lipoprotein in Humans for a Better Understanding of Lipoprotein(a) Metabolism Under PCSK9 Variations (Hu-La-u-P Study)
Enrollment Status: Completed
Publish Date: February 23, 2022
Intervention Type: Other
Study Phase: Not Applicable
Relevance of Plasma PCSK9 Concentration as a Biomarker in Acute Coronary Syndrome.
Relevance of Plasma PCSK9 Concentration as a Biomarker in Acute Coronary Syndrome.
Enrollment Status: Completed
Publish Date: September 20, 2021
Intervention Type: Other
Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes : A Randomized Double-blind Placebo-controlled Trial
Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes : A Randomized Double-blind Placebo-controlled Trial
Enrollment Status: Completed
Publish Date: July 08, 2021
Intervention Type: Drug
Study Drug: Dulaglutide
Study Phase: Phase 2
Study of cardiovAscular Contrasted Phenotypes in Patients With FamIliaI hypercholesteRolemia
Study of cardiovAscular Contrasted Phenotypes in Patients With FamIliaI hypercholesteRolemia
Enrollment Status: Completed
Publish Date: May 24, 2021
Intervention Type: Genetic
Study Phase: Not Applicable
View 8 Less Clinical Trials

303 Total Publications

Versatile Functions of Hepatic Lipase in Lipoprotein Metabolism.
Versatile Functions of Hepatic Lipase in Lipoprotein Metabolism.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Cariou's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 9 Advanced Conditions
View All 51 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile